STING1 and cancer: To confirm STING's cytoplasm-to-nucleus translocation under various DNA damage treatments (BMN673, olaparib, and lipopolysaccharide), we used immunofluorescence in multiple cancer cell lines (HeLa, 769P, B16 cells) (Fig. 1E–G; Fig. S2A–S2F).